These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1722790)
21. [The current approach to the management of benign hypertrophy of the prostate]. Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352 [TBL] [Abstract][Full Text] [Related]
23. Turbulent urinary flow in the urethra could be a causal factor for benign prostatic hyperplasia. Martinez-Borges AR Med Hypotheses; 2006; 67(4):871-5. PubMed ID: 16764996 [TBL] [Abstract][Full Text] [Related]
24. Benign prostatic hyperplasia: does lifestyle play a role? Barnard RJ; Aronson WJ Phys Sportsmed; 2009 Dec; 37(4):141-6. PubMed ID: 20048551 [TBL] [Abstract][Full Text] [Related]
25. [Relation between benign prostatic hyperplasia and obesity and estrogen]. Matsuda T; Abe H; Suda K Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594 [TBL] [Abstract][Full Text] [Related]
27. [Pathophysiology of benign prostatic hyperplasia]. Frick J Wien Med Wochenschr; 1996; 146(8):158-60. PubMed ID: 8767399 [TBL] [Abstract][Full Text] [Related]
28. [The frequency of surgery of benign prostatic hypertrophy]. Janin P; Haillot O; Boutin JM; Lesourd B; Hubert B; Lanson Y Prog Urol; 1995 Sep; 5(4):515-21. PubMed ID: 7581501 [TBL] [Abstract][Full Text] [Related]
29. [Benign hypertrophy of the prostate: pathogenic aspects]. Páez Borda A; Fernández Lucas C; Diego García A; Prieto Chaparro L; Gómez Ruiz JJ; Rapariz González M; Silmi Moyano A; Salinas Casado J; Blázquez Izquierdo J; Usón Calvo A Arch Esp Urol; 1991 Apr; 44(3):229-36. PubMed ID: 1714264 [TBL] [Abstract][Full Text] [Related]
30. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594 [TBL] [Abstract][Full Text] [Related]
31. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia? Hall MC; Roehrborn CG; McConnell JD Semin Urol Oncol; 1996 Aug; 14(3):122-33. PubMed ID: 8865473 [TBL] [Abstract][Full Text] [Related]
32. The natural history of benign prostatic hyperplasia. Fitzpatrick JM BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045 [TBL] [Abstract][Full Text] [Related]
33. Relative proportions of tissue components in the prostate: are they related to the development of symptomatic BPH in Korean men? Byun SS; Jeong H; Jo MK; Lee E Urology; 2005 Sep; 66(3):593-6. PubMed ID: 16140084 [TBL] [Abstract][Full Text] [Related]
34. Benign prostatic hyperplasia. Jonler M; Riehmann M; Brinkmann R; Bruskewitz RC Endocrinol Metab Clin North Am; 1994 Dec; 23(4):795-807. PubMed ID: 7535688 [TBL] [Abstract][Full Text] [Related]
35. Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. Jakobsen H; Torp-Pedersen S; Juul N Scand J Urol Nephrol Suppl; 1988; 107():26-31. PubMed ID: 2453919 [TBL] [Abstract][Full Text] [Related]